{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T19:57:59Z","timestamp":1768420679939,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Applied Radiation and Isotopes"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.apradiso.2023.111162","type":"journal-article","created":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T21:11:46Z","timestamp":1703106706000},"page":"111162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Case report of radiotherapy combined with anlotinib and immunotherapy for a patient with esophageal cancer and esophageal fistula"],"prefix":"10.1016","volume":"205","author":[{"given":"Lumei","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8921-612X","authenticated-orcid":false,"given":"Qian","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haodong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.apradiso.2023.111162_bib1","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1053\/j.gastro.2017.08.023","article-title":"Epidemiology of esophageal squamous cell carcinoma","volume":"154","author":"Abnet","year":"2018","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.apradiso.2023.111162_bib2","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ijrobp.2017.02.003","article-title":"Multicenter evaluation of the tolerability of combined treatment with PD-1 and CTLA-4 immune checkpoint inhibitors and palliative radiation therapy","volume":"98","author":"Bang","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"8","key":"10.1016\/j.apradiso.2023.111162_bib3","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm730","article-title":"Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion","volume":"8","author":"Dong","year":"2002","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.apradiso.2023.111162_bib4","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3892\/ol.2020.11685","article-title":"Anlotinib as a molecular targeted therapy for tumors","volume":"20","author":"Gao","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.apradiso.2023.111162_bib5","article-title":"Anlotinib inhibits tumor angiogenesis and promotes the anticancer effect of radiotherapy on esophageal cancer through inhibiting EphA2","volume":"2022","author":"Gu","year":"2022","journal-title":"JAMA Oncol."},{"issue":"6","key":"10.1016\/j.apradiso.2023.111162_bib6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s11748-013-0246-0","article-title":"Treatments for esophageal cancer: a review","volume":"61","author":"Kato","year":"2013","journal-title":"Gen. Thorac. Cardiovasc Surg."},{"issue":"5","key":"10.1016\/j.apradiso.2023.111162_bib7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.21037\/cco.2017.07.06","article-title":"Systemic therapy for esophageal cancer: chemotherapy","volume":"6","author":"Ku","year":"2017","journal-title":"Chin. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.apradiso.2023.111162_bib8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13046-019-1093-3","article-title":"Autophagy inhibition potentiates the anti-angiogenic property of multikinase inhibitor anlotinib through JAK2\/STAT3\/VEGFA signaling in non-small cell lung cancer cells","volume":"38","author":"Liang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.apradiso.2023.111162_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.gene.2018.02.026","article-title":"Anlotinib inhibits angiogenesis via suppressing the activation of VEGFR2, PDGFR\u03b2 and FGFR1","volume":"654","author":"Lin","year":"2018","journal-title":"Gene"},{"key":"10.1016\/j.apradiso.2023.111162_bib10","article-title":"Efficacy and safety of anlotinib plus programmed death-1 blockade versus anlotinib monotherapy as second or further-line treatment in advanced esophageal squamous cell carcinoma: a retrospective study","volume":"12","author":"Liu","year":"2022","journal-title":"Front. Oncol."},{"issue":"18","key":"10.1016\/j.apradiso.2023.111162_bib11","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.3390\/cancers13184632","article-title":"Immunotherapy for esophageal cancers: what is practice changing in 2021?","volume":"13","author":"Puhr","year":"2021","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.apradiso.2023.111162_bib12","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ctrv.2015.03.011","article-title":"The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant","volume":"41","author":"Reynders","year":"2015","journal-title":"Cancer Treat Rev."},{"issue":"1","key":"10.1016\/j.apradiso.2023.111162_bib13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1530\/ERC-17-0558","article-title":"Antitumor effects of anlotinib in thyroid cancer","volume":"26","author":"Ruan","year":"2019","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.apradiso.2023.111162_bib14","doi-asserted-by":"crossref","first-page":"995","DOI":"10.3389\/fonc.2020.00995","article-title":"Anlotinib combined with chemoradiotherapy exhibits significant therapeutic efficacy in esophageal squamous cell carcinoma","volume":"10","author":"Shi","year":"2020","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.apradiso.2023.111162_bib15","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1007\/s12328-020-01237-x","article-title":"Epidemiology of esophageal cancer: update in global trends, etiology and risk factors","volume":"13","author":"Uhlenhopp","year":"2020","journal-title":"Clin. J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.apradiso.2023.111162_bib16","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/ijc.32180","article-title":"Anlotinib, a novel small molecular tyrosine kinase inhibitor, suppresses growth and metastasis via dual blockade of VEGFR2 and MET in osteosarcoma","volume":"145","author":"Wang","year":"2019","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.apradiso.2023.111162_bib17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s00595-019-01878-7","article-title":"Recent progress in multidisciplinary treatment for patients with esophageal cancer","volume":"50","author":"Watanabe","year":"2020","journal-title":"Surg. Today"},{"issue":"10","key":"10.1016\/j.apradiso.2023.111162_bib18","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1007\/s11864-022-01003-w","article-title":"Approach to localized squamous cell cancer of the esophagus","volume":"23","author":"Weidenbaum","year":"2022","journal-title":"Curr. Treat. Options Oncol."},{"issue":"4","key":"10.1016\/j.apradiso.2023.111162_bib19","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/cas.13536","article-title":"Preclinical characterization of anlotinib, a highly potent and selective vascular endothelial growth factor receptor-2 inhibitor","volume":"109","author":"Xie","year":"2018","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.apradiso.2023.111162_bib20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13019-020-01202-2","article-title":"The treatments and postoperative complications of esophageal cancer: a review","volume":"15","author":"Xu","year":"2020","journal-title":"J. Cardiothorac. Surg."},{"issue":"10","key":"10.1016\/j.apradiso.2023.111162_bib21","first-page":"6578","article-title":"Combined treatment with anlotinib and chemotherapy for advanced esophageal squamous cell carcinoma improved patient survival: a case report","volume":"12","author":"Yang","year":"2020","journal-title":"Am. J. Transl. Res."},{"issue":"31","key":"10.1016\/j.apradiso.2023.111162_bib22","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.2217\/fon-2020-0222","article-title":"Effective combinations of radiotherapy and immunotherapy in the treatment of esophageal squamous cell carcinoma","volume":"16","author":"Yang","year":"2020","journal-title":"Future Oncol."}],"container-title":["Applied Radiation and Isotopes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969804323005158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969804323005158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T04:24:02Z","timestamp":1760847842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969804323005158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":22,"alternative-id":["S0969804323005158"],"URL":"https:\/\/doi.org\/10.1016\/j.apradiso.2023.111162","relation":{},"ISSN":["0969-8043"],"issn-type":[{"value":"0969-8043","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Case report of radiotherapy combined with anlotinib and immunotherapy for a patient with esophageal cancer and esophageal fistula","name":"articletitle","label":"Article Title"},{"value":"Applied Radiation and Isotopes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apradiso.2023.111162","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111162"}}